Review
doi: 10.1097/NRL.0000000000000085.Neurological Management of Von Hippel-Lindau Disease
Affiliations
- PMID:27564075
- DOI: 10.1097/NRL.0000000000000085
Item in Clipboard
Review
Neurological Management of Von Hippel-Lindau Disease
Trent S Hodgson et al. Neurologist.2016 Sep.
Display options
Format
Display options
Format
Abstract
Von Hippel-Lindau disease is a genetic condition due to mutation of the Von Hippel-Lindau gene, which leads to an increased risk in the development of hemangioblastomas of the brain and spinal cord. The pathophysiology of disease and its clinical manifestations, as they pertain to the general neurologist, are discussed. Therapeutic management of central nervous system hemangioblastomas ranging from neurosurgical resection, radiation therapy, and systemic therapies is reviewed.
Similar articles
- [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].Richard S, Martin S, David P, Decq P.Richard S, et al.Neurochirurgie. 1998 Nov;44(4):258-66.Neurochirurgie. 1998.PMID:9864697Review.French.
- Continuous angiogenesis inhibition in the treatment for von Hippel-Lindau-related hemangioblastomas of retina and spinal cord.Salim DK.Salim DK.J Oncol Pharm Pract. 2019 Dec;25(8):2049-2051. doi: 10.1177/1078155219827635. Epub 2019 Feb 5.J Oncol Pharm Pract. 2019.PMID:31694494
- Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D.Conway JE, et al.Neurosurgery. 2001 Jan;48(1):55-62; discussion 62-3. doi: 10.1097/00006123-200101000-00009.Neurosurgery. 2001.PMID:11152361
- [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].Sankaredja J, Brac B, Thines L, Baroncini M, Zairi F, Cardot-Bauters C, Lejeune JP.Sankaredja J, et al.Rev Neurol (Paris). 2014 Apr;170(4):288-96. doi: 10.1016/j.neurol.2013.12.005. Epub 2014 Mar 27.Rev Neurol (Paris). 2014.PMID:24680832French.
- Management of von Hippel-Lindau disease-associated CNS lesions.Wind JJ, Lonser RR.Wind JJ, et al.Expert Rev Neurother. 2011 Oct;11(10):1433-41. doi: 10.1586/ern.11.124.Expert Rev Neurother. 2011.PMID:21955200Review.
Cited by
- Neurological applications of belzutifan in von Hippel-Lindau disease.Zhang Y, Nguyen CC, Zhang NT, Fink NS, John JD, Venkatesh OG, Roe JD, Hoffman SC, Lesniak MS, Wolinsky JP, Horbinski C, Szymaniak BM, Buerki RA, Sosman JA, Shenoy NK, Lukas RV.Zhang Y, et al.Neuro Oncol. 2023 May 4;25(5):827-838. doi: 10.1093/neuonc/noac234.Neuro Oncol. 2023.PMID:36215167Free PMC article.
- The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors.Esparragosa Vazquez I, Ducray F.Esparragosa Vazquez I, et al.Cancers (Basel). 2024 Aug 6;16(16):2781. doi: 10.3390/cancers16162781.Cancers (Basel). 2024.PMID:39199553Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical